A hundred and two initial public offerings have been priced so far this year as of May 25th, 2007:

- 69 IPOs are currently trading above initial offering price;
- 31 are trading below the offering price;
- and 2 are trading at their offer price.

Seven IPOs were priced during the week of May 21st, 2007. There are four deals on deck for the next week, hoping to raise nearly $800 million.

IPO PERFORMANCE

ADVANCERS:

The Cayman Islands-based Greenlight Capital Re (GLRE: chart) on Thursday priced its initial public offering of 10.25 million at $19 per share, above the expected range of $16 to $18. The deal was worth $194.8 million.

Shares of the company rose as much as 26.3% on the first day of trading.

Greenlight Re granted the underwriters an option to purchase up to 1.5 million additional shares to cover allotments.

Lehman Brothers and UBS Securities were acting as lead managers for the initial public offering.

Greenlight Re is a specialty property and casualty reinsurance company based in the Cayman Islands.

The shares ended the week at $24.78, up 30% from the offering price.

Sirtris Pharmaceuticals, Inc. (SIRT: chart) priced its initial public offering of 6 million shares at $10 per share, at the midpoint of the anticipated price range of $9 to $11.

The company raised the number of shares offered to 6 million, from 5 million.

All of the common stock is being offered by the company.

J.P. Morgan was acting as the lead manager and CIBC World Markets, Piper Jaffray, JMP Securities, and Rodman & Renshaw were acting as co-managers for the offering.

In addition, Sirtris has granted the underwriters a 30-day option to purchase up to 900,000 shares to cover over-allotments.

The Cambridge, Massachusetts-based Sirtris Pharmaceuticals is a biopharmaceutical company focused on discovering and developing proprietary, orally available, small molecule drugs with the potential to treat diseases associated with aging, including metabolic diseases such as Type 2 Diabetes.

The shares ended the week at $12.59, up 25% from the offering price.

STARLIMS Technologies Ltd. (LIMS: chart) on Thursday priced its public offering of 2.1 million of its ordinary shares at $13.50 per share, the low end of the anticipated range of $13.50 and $15.50.

The Tel Aviv, Israel-based company raised about $25.5 million from the offering.

Oppenheimer & Co. was acting as a manager and JMP Securities was acting as co-lead manager of the offering.

The underwriters have been granted a 30-day option to purchase up to 315,000 additional shares to cover over-allotments.